Hotchkis & Wiley Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,800
| Closed | -$1.55M | – | 524 |
|
|
2022
Q3 | $1.55M | Buy |
4,800
+100
| +2% | +$31.7K | 0.01% | 491 |
|
|
2022
Q2 | $1.52M | Sell |
4,700
-2,100
| -31% | -$630K | 0.01% | 477 |
|
|
2022
Q1 | $1.95M | Sell |
6,800
-300
| -4% | -$77.2K | 0.01% | 471 |
|
|
2021
Q4 | $1.96M | Sell |
7,100
-2,000
| -22% | -$507K | 0.01% | 471 |
|
|
2021
Q3 | $2.1M | Hold |
9,100
| – | – | 0.01% | 454 |
|
|
2021
Q2 | $2.09M | Hold |
9,100
| – | – | 0.01% | 459 |
|
|
2021
Q1 | $1.7M | Sell |
9,100
-800
| -8% | -$156K | 0.01% | 460 |
|
|
2020
Q4 | $1.67M | Sell |
9,900
-300
| -3% | -$44.8K | 0.01% | 453 |
|
|
2020
Q3 | $1.51M | Sell |
10,200
-1,800
| -15% | -$279K | 0.01% | 388 |
|
|
2020
Q2 | $1.97M | Hold |
12,000
| – | – | 0.01% | 382 |
|
|
2020
Q1 | $1.67M | Hold |
12,000
| – | – | 0.01% | 379 |
|
|
2019
Q4 | $1.58M | Hold |
12,000
| – | – | 0.01% | 447 |
|
|
2019
Q3 | $1.34M | Hold |
12,000
| – | – | 0.01% | 440 |
|
|
2019
Q2 | $1.33M | Sell |
12,000
-1,400
| -10% | -$165K | 0.01% | 443 |
|
|
2019
Q1 | $1.74M | Sell |
13,400
-900
| -6% | -$109K | 0.01% | 398 |
|
|
2018
Q4 | $1.66M | Sell |
14,300
-6,300
| -31% | -$704K | 0.01% | 385 |
|
|
2018
Q3 | $2.21M | Sell |
20,600
-2,400
| -10% | -$240K | 0.01% | 374 |
|
|
2018
Q2 | $1.96M | Sell |
23,000
-1,900
| -8% | -$156K | 0.01% | 317 |
|
|
2018
Q1 | $1.93M | Hold |
24,900
| – | – | 0.01% | 153 |
|
|
2017
Q4 | $2.1M | Sell |
24,900
-1,300
| -5% | -$111K | 0.01% | 144 |
|
|
2017
Q3 | $2.24M | Sell |
26,200
-700
| -3% | -$57.4K | 0.01% | 148 |
|
|
2017
Q2 | $2.21M | Hold |
26,900
| – | – | 0.01% | 151 |
|
|
2017
Q1 | $2.26M | Hold |
26,900
| – | – | 0.01% | 149 |
|
|
2016
Q4 | $1.98M | Hold |
26,900
| – | – | 0.01% | 151 |
|
|
2016
Q3 | $2.16M | Hold |
26,900
| – | – | 0.01% | 156 |
|
|
2016
Q2 | $2.12M | Hold |
26,900
| – | – | 0.01% | 157 |
|
|
2016
Q1 | $1.94M | Hold |
26,900
| – | – | 0.01% | 156 |
|
|
2015
Q4 | $2.27M | Hold |
26,900
| – | – | 0.01% | 161 |
|
|
2015
Q3 | $2.25M | Sell |
26,900
-3,841,209
| -99% | -$324M | 0.01% | 168 |
|
|
2015
Q2 | $323M | Sell |
3,868,109
-99,930
| -3% | -$7.61M | 1.14% | 27 |
|
|
2015
Q1 | $288M | Buy |
3,968,039
+27,452
| +0.7% | +$1.95M | 1% | 35 |
|
|
2014
Q4 | $272M | Sell |
3,940,587
-381,079
| -9% | -$25.7M | 0.95% | 35 |
|
|
2014
Q3 | $280M | Sell |
4,321,666
-529,814
| -11% | -$33.5M | 1.02% | 36 |
|
|
2014
Q2 | $302M | Buy |
4,851,480
+3,232,678
| +200% | +$193M | 1.07% | 31 |
|
|
2014
Q1 | $95.3M | Buy |
+1,618,802
| New | +$90.3M | 0.35% | 74 |
|
Other funds holding LLY
Hotchkis & Wiley Capital Management's LLY Position: Q4 2022 in Review
Hotchkis & Wiley Capital Management sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 4,800 shares — an estimated $1.55M sold.
Hotchkis & Wiley Capital Management first reported a position in LLY in Q1 2014 and held it in 35 quarters. The position peaked at $323M in Q2 2015. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Hotchkis & Wiley Capital Management reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
- Hotchkis & Wiley Capital Management sold 4,800 Eli Lilly shares in Q4 2022, an estimated $1.55M.
- Hotchkis & Wiley Capital Management first reported a position in Eli Lilly in Q1 2014 and held it in 35 quarters.
- Hotchkis & Wiley Capital Management's Eli Lilly position peaked at $323M in Q2 2015.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Hotchkis & Wiley Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.